PsyAccess
Am I eligible?
Am I eligible?
Spravato®Registry-verifiedDesignated-centers model

Universitäres Psychiatrisches Zentrum Bern (UPZ, vormals UPD)

Bern, Switzerland

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeCovered by a national programme
  • Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 58 630 91 11
  • Websitehttps://www.upz-bern.ch/

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

About this provider

Universitäres Psychiatrisches Zentrum Bern (UPZ) is the university psychiatric centre for the canton of Bern, created on 1 July 2026 from the merger of Universitäre Psychiatrische Dienste Bern (UPD) and PZM Psychiatriezentrum Münsingen, with its main site at Bolligenstrasse 111. UPZ covers the full psychiatric care chain (outpatient, day-clinic and inpatient) and runs dedicated adult treatment programmes for treatment-resistant disorders and interventional psychiatry; it is listed as a designated Spravato (esketamine) centre on the BAG Limitatio list.

Services & programs

  • Treatment-resistant disorders programme (Behandlungsschwerpunkt Behandlungsresistente Störungen)
  • Interventional psychiatry (Behandlungsschwerpunkt Interventionelle Psychiatrie)
  • Esketamine (Spravato) as BAG-designated centre
  • Inpatient, day-clinic, outpatient and consultative adult psychiatry
  • Affective disorders programme

Common questions

How is esketamine treatment accessed at UPD Bern?

UPD's KIPAP centre treats treatment-resistant depression and lists intranasal esketamine among its procedures. Access to the Swiss Spravato route runs through a psychiatrist, who confirms the eligibility criteria and obtains the health insurer's cost approval (Kostengutsprache) before the first dose.

Who qualifies for reimbursed Spravato in Switzerland?

Basic insurance (OKP) covers it under a Limitatio: adults 18-74 whose current episode has not responded to at least two antidepressants plus one augmentation attempt, with CGI-S severity of 5 or more, insurer pre-approval before the first dose, and a maximum of 10 months of treatment.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

21 more verified providers within 50 km

See them on the provider map →

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Universitäres Psychiatrisches Zentrum Bern (UPZ, vormals UPD) only with your explicit consent, and you can download it for yourself either way.

Why enquire via PsyAccess

  • Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
  • A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
  • Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.
Check my fit & enquire

About two minutes. The check itself runs in your browser: your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.

Check my fit & enquire